KRISTIN BALLARD: Open Payments
NPI 1861956104 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$397 in 21 payments from 9 companies in 2025. Trend: 2023 $78 · 2024 $410 · 2025 $397
Food & beverage: $397
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $180 |
| Lilly USA, LLC | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
| SANOFI-AVENTIS U.S. LLC | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| PFIZER INC. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: Wegovy, JARDIANCE, Ozempic, MOUNJARO, TZIELD, XIFAXAN, PREVNAR 20, SHINGRIX.
Industry payments across NC — which companies pay providers there.
